89 related articles for article (PubMed ID: 9759939)
1. Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.
Ye X; Gao GP; Pabin C; Raper SE; Wilson JM
Hum Gene Ther; 1998 Sep; 9(14):2135-42. PubMed ID: 9759939
[TBL] [Abstract][Full Text] [Related]
2. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
[TBL] [Abstract][Full Text] [Related]
4. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery.
Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H
J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035
[TBL] [Abstract][Full Text] [Related]
5. No evidence of germ-line transmission by adenovirus-mediated gene transfer to mouse testes.
Kojima Y; Hayashi Y; Kurokawa S; Mizuno K; Sasaki S; Kohri K
Fertil Steril; 2008 May; 89(5 Suppl):1448-54. PubMed ID: 17624347
[TBL] [Abstract][Full Text] [Related]
6. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration.
Peeters MJ; Patijn GA; Lieber A; Meuse L; Kay MA
Hum Gene Ther; 1996 Sep; 7(14):1693-9. PubMed ID: 8886840
[TBL] [Abstract][Full Text] [Related]
8. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated in vivo gene transfer rapidly protects ornithine transcarbamylase-deficient mice from an ammonium challenge.
Ye X; Robinson MB; Pabin C; Quinn T; Jawad A; Wilson JM; Batshaw ML
Pediatr Res; 1997 Apr; 41(4 Pt 1):527-34. PubMed ID: 9098855
[TBL] [Abstract][Full Text] [Related]
10. Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors.
Ye X; Zimmer KP; Brown R; Pabin C; Batshaw ML; Wilson JM; Robinson MB
Hum Gene Ther; 2001 Jun; 12(9):1035-46. PubMed ID: 11399226
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector-mediated gene transfer to regional lymph nodes.
Labow D; Lee S; Ginsberg RJ; Crystal RG; Korst RJ
Hum Gene Ther; 2000 Mar; 11(5):759-69. PubMed ID: 10757355
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
13. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes.
Morsy MA; Alford EL; Bett A; Graham FL; Caskey CT
J Clin Invest; 1993 Sep; 92(3):1580-6. PubMed ID: 8376608
[TBL] [Abstract][Full Text] [Related]
14. Direct exposure of mouse ovaries and oocytes to high doses of an adenovirus gene therapy vector fails to lead to germ cell transduction.
Gordon JW
Mol Ther; 2001 Apr; 3(4):557-64. PubMed ID: 11319918
[TBL] [Abstract][Full Text] [Related]
15. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.
Raper SE; Chirmule N; Lee FS; Wivel NA; Bagg A; Gao GP; Wilson JM; Batshaw ML
Mol Genet Metab; 2003; 80(1-2):148-58. PubMed ID: 14567964
[TBL] [Abstract][Full Text] [Related]
16. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
[TBL] [Abstract][Full Text] [Related]
17. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
[TBL] [Abstract][Full Text] [Related]
18. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors.
Okuyama T; Li XK; Funeshima N; Fujino M; Sasaki K; Kita Y; Kosuga M; Takahashi M; Saito H; Suzuki S; Yamada M
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S113-8. PubMed ID: 9792044
[TBL] [Abstract][Full Text] [Related]
19. Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors.
Camargo FD; Huey-Louie DA; Finn AV; Sassani AB; Cozen AE; Moriwaki H; Schneider DB; Agah R; Dichek DA
Mol Ther; 2000 Nov; 2(5):496-504. PubMed ID: 11082323
[TBL] [Abstract][Full Text] [Related]
20. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.
Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M
Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
